Benzinga's Top #PreMarket Gainers

shares rose 35.70 percent to $6.31 in pre-market trading after the company agreed to be acquired by Leyard for $6.58 per share.

gained 17.36 percent to $4.80 in pre-market trading. Eleven Biotherapeutics reported a Q2 loss of $0.36 per share on revenue of $114 thousand.

shares climbed 5.93 percent to $14.30 in pre-market trading after the company priced its 5.4 million share offering at $12.75 per share.

shares rose 3.63 percent to $107.25 in pre-market trading. Morgan Stanley initiated coverage on GW Pharmaceuticals with a Overweight rating and a $150.00 price target.

shares rose 3.58 percent to $28.90 in pre-market trading after the company reported better-than-expected results for its fiscal fourth quarter on Wednesday.